TR200000134T2 - Tiazolidinedion, ensülin salgılatıcısı ve biguanid ile diabetin (şeker hastalığının) tedavisi. - Google Patents

Tiazolidinedion, ensülin salgılatıcısı ve biguanid ile diabetin (şeker hastalığının) tedavisi.

Info

Publication number
TR200000134T2
TR200000134T2 TR2000/00134T TR200000134T TR200000134T2 TR 200000134 T2 TR200000134 T2 TR 200000134T2 TR 2000/00134 T TR2000/00134 T TR 2000/00134T TR 200000134 T TR200000134 T TR 200000134T TR 200000134 T2 TR200000134 T2 TR 200000134T2
Authority
TR
Turkey
Prior art keywords
diabetes
thiazolidinedione
biguanide
treatment
insulin secretagogue
Prior art date
Application number
TR2000/00134T
Other languages
English (en)
Inventor
Edwin Buckingham Robin
Alistair Smith Stephen
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR200000134T2 publication Critical patent/TR200000134T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Etkili, toksin olmayan ve eczacilik teknolojisi bakimindan kabul edilebilir tutarda bir ensülin yönünden duyarli duruma getiricinin, bir insülin salgilattiricisinin bir biguanid, bunlara gereksinmesi bulunan bir memeliye verilmesini içeren diabetes mellitus'un ve memelide diabetes mellitus ile iliskili durumlarin tedavi edilmeleri için yöntem ile bu gibi yöntemin kullanilmasina yarar bilesim.
TR2000/00134T 1997-07-18 1998-07-16 Tiazolidinedion, ensülin salgılatıcısı ve biguanid ile diabetin (şeker hastalığının) tedavisi. TR200000134T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9715295A GB9715295D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
TR200000134T2 true TR200000134T2 (tr) 2000-09-21

Family

ID=10816167

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00134T TR200000134T2 (tr) 1997-07-18 1998-07-16 Tiazolidinedion, ensülin salgılatıcısı ve biguanid ile diabetin (şeker hastalığının) tedavisi.

Country Status (39)

Country Link
EP (1) EP1001783B1 (tr)
JP (2) JP2001510159A (tr)
KR (1) KR100671918B1 (tr)
CN (1) CN1264303A (tr)
AP (1) AP1352A (tr)
AR (1) AR016349A1 (tr)
AT (1) ATE305790T1 (tr)
AU (1) AU8448898A (tr)
BG (1) BG64785B1 (tr)
BR (1) BR9810445A (tr)
CA (1) CA2296653C (tr)
CO (1) CO4940420A1 (tr)
CY (1) CY1105254T1 (tr)
DE (1) DE69831808T2 (tr)
DK (1) DK1001783T3 (tr)
DZ (1) DZ2562A1 (tr)
EA (1) EA003021B1 (tr)
ES (1) ES2251093T3 (tr)
GB (1) GB9715295D0 (tr)
HU (1) HUP0003629A3 (tr)
ID (1) ID24211A (tr)
IL (1) IL134046A0 (tr)
IN (1) IN189275B (tr)
MA (1) MA24607A1 (tr)
MY (1) MY155219A (tr)
NO (1) NO325727B1 (tr)
NZ (2) NZ511608A (tr)
OA (1) OA11279A (tr)
PE (1) PE99599A1 (tr)
PL (2) PL197844B1 (tr)
SA (1) SA98190468B1 (tr)
SI (1) SI1001783T1 (tr)
SK (1) SK285484B6 (tr)
TR (1) TR200000134T2 (tr)
TW (1) TW505516B (tr)
UA (1) UA70303C2 (tr)
UY (1) UY25102A1 (tr)
WO (1) WO1999003477A1 (tr)
ZA (1) ZA986363B (tr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
CZ20011629A3 (cs) * 1998-11-12 2001-12-12 Smithkline Beecham Plc Farmaceutický prostředek pro upravené uvolňování senzitizéru inzulínu a jiných antidiabetických přípravků
SE9902918D0 (sv) * 1999-08-13 1999-08-13 Pharmacia & Upjohn Ab Methods for identification of compounds stimulating insulin secretion
AU1403501A (en) * 1999-11-16 2001-05-30 Smithkline Beecham Plc Novel composition and use
AR030920A1 (es) * 1999-11-16 2003-09-03 Smithkline Beecham Plc Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus, y procedimientos para preparar dichas composiciones
FR2812547B1 (fr) * 2000-08-04 2002-10-31 Lipha Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
CA2725833A1 (en) 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Spaced drug delivery system
ITFI20010126A1 (it) * 2001-07-09 2003-01-09 Molteni & C Composizioni farmaceutiche per uso orale,contenenti,in combinazione,metformina e gliclazide
AU2001273289B2 (en) * 2001-07-10 2004-10-07 Kos Life Sciences, Inc. Core formulation comprising pioglitazone hydrochloride and a biguanide
WO2003105809A1 (en) 2002-06-17 2003-12-24 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
KR20120034211A (ko) * 2002-09-20 2012-04-10 안드렉스 랩스 엘엘씨 약제학적 정제
UA80991C2 (en) 2002-10-07 2007-11-26 Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
GEP20084570B (en) 2003-10-31 2008-12-25 Takeda Pharmaceutical Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
MXPA05010977A (es) * 2005-10-12 2007-04-11 Abdala Leopoldo Espinosa Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus.
KR100812538B1 (ko) * 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제
CN101417130B (zh) * 2007-10-22 2010-10-06 鲁南制药集团股份有限公司 一种治疗ⅱ型糖尿病及其并发症的药物组合物
EP3698801B1 (en) * 2017-10-20 2024-09-04 Novmetapharma Co., Ltd. Pharmaceutical composition for preventing or treating diabetes, containing zinc salt, cyclo-hispro and antidiabetic drug as active ingredients

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
MX15171A (es) * 1988-03-08 1993-05-01 Pfizer Derivados de tiazolidinodiona hipoglicemicos
WO1989008650A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Thiazolidinedione hypoglycemic agents
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
DE69219136T2 (de) * 1991-08-26 1997-08-28 Pharmacia & Upjohn Co., Kalamazoo, Mich. Flüssiges nahrungsmittel, das 3-guanidinopropionsäure enthält
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
DE69837089T2 (de) * 1997-06-18 2007-06-21 Smithkline Beecham P.L.C., Brentford Behandlung der diabetes mit thiazolidindion und sulfonylharnstoff

Also Published As

Publication number Publication date
BG104135A (en) 2000-10-31
AU8448898A (en) 1999-02-10
TW505516B (en) 2002-10-11
EA200000139A1 (ru) 2000-06-26
DK1001783T3 (da) 2006-02-06
NZ511608A (en) 2002-12-20
WO1999003477A1 (en) 1999-01-28
SK592000A3 (en) 2000-09-12
CA2296653C (en) 2007-10-02
BG64785B1 (bg) 2006-04-28
JP2005213273A (ja) 2005-08-11
BR9810445A (pt) 2000-09-05
CN1264303A (zh) 2000-08-23
HUP0003629A3 (en) 2003-04-28
DE69831808D1 (de) 2006-02-16
CO4940420A1 (es) 2000-07-24
UY25102A1 (es) 2000-12-29
GB9715295D0 (en) 1997-09-24
PL198017B1 (pl) 2008-05-30
ID24211A (id) 2000-07-13
PL338126A1 (en) 2000-09-25
CY1105254T1 (el) 2010-03-03
EP1001783B1 (en) 2005-10-05
SA98190468B1 (ar) 2007-01-20
NO20000228D0 (no) 2000-01-17
OA11279A (en) 2003-07-31
PL197844B1 (pl) 2008-05-30
SI1001783T1 (sl) 2006-02-28
ZA986363B (en) 2000-01-17
PE99599A1 (es) 1999-12-18
AP1352A (en) 2004-12-24
HUP0003629A2 (hu) 2001-07-30
EP1001783A1 (en) 2000-05-24
NO20000228L (no) 2000-01-17
CA2296653A1 (en) 1999-01-28
KR20010021947A (ko) 2001-03-15
AR016349A1 (es) 2001-07-04
NO325727B1 (no) 2008-07-07
AP2000001733A0 (en) 2000-03-31
IN189275B (tr) 2003-01-25
EA003021B1 (ru) 2002-12-26
ATE305790T1 (de) 2005-10-15
HK1028550A1 (en) 2001-02-23
UA70303C2 (uk) 2004-10-15
SK285484B6 (sk) 2007-02-01
IL134046A0 (en) 2001-04-30
MA24607A1 (fr) 1999-04-01
MY155219A (en) 2015-09-30
KR100671918B1 (ko) 2007-01-22
JP2001510159A (ja) 2001-07-31
ES2251093T3 (es) 2006-04-16
DE69831808T2 (de) 2006-07-06
NZ501164A (en) 2001-06-29
DZ2562A1 (fr) 2003-02-15

Similar Documents

Publication Publication Date Title
TR199902033T2 (tr) Diyabet için sülfonilura-glitazon sinerjik kombinasyonlari.
NO20090846L (no) Kombinasjon og farmasoytisk blanding for behandling av diabetes samt anvendelse derav
TR200100079T2 (tr) Glikoza karşı ß-hücre tepkisini arttıran glukagon benzeri peptid-1
RU93053497A (ru) Новые пептиды-агонисты и их использование
NO940436D0 (no) Forlenget avgivelse av peptider
FR2709423B1 (fr) Réservoir imprégnable d'une solution de principe actif, pour dispositif ionophorétique d'administration transdermique de médicaments, et procédé de fabrication d'un tel réservoir.
DE69327309D1 (de) Verwendung eines peptids
YU37301A (sh) Farmaceutski preparat za modifikovano oslobađanje sensitizera insulina i drugog antidijabetskog agensa
DK273090D0 (da) Laasecylinder og noegle saavel som noegleemne med ens sikkerhedsindretning
ES2122995T3 (es) Procedimientos y composiciones para el tratamiento de la diabetes mellitus, hipoglicemia y otros estados patologicos.
CY1105254T1 (el) Θepαπεια του διαβητη με θειαζολιδινδιονη, εκκριταγωγο ινσουλινης και διγουανιδιο
TR200000135T2 (tr) Tiazolidinedion ve sülfonilüre ile diabet tedavisi.
TR200503846T2 (tr) Değiştirilmiş salimli ensülin sensitizörü için fterkip ve kullanımı
AR012997A1 (es) Uso de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4- diona e insulina para la preparacion de medicamentos, y composicionfarmaceutica que los contiene.
TR200000133T2 (tr) Tiazolidinedion, ensülin salgılattırıcısı ve alfa glükosidaz inhibitörü ile diabetin (şeker hastasının) tedavisi.
TR199903096T2 (tr) Diabetin tiazolidinedion ve sülfonilüre ile tedavisi.
ATE252913T1 (de) Vorbeugung einer krankheit mit diabetes charakter
TR199903072T2 (tr) Diabetin tiazolidinedion ve alfa-glukosidaz ile tedavisi.
TR199801298T2 (tr) ACE-engelleyicinin dispeptik semptomlarin tedavisinde yeni tibbi kullanimi.
TR200000957T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı
CO5150158A1 (es) Tratamiento antidiabetico novedoso
TR200000958T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı.
MX9705920A (es) Tratamiento de neuropatia diabetica.
HUP0002668A2 (hu) Diabetes kezelésére dioxo-tiazolidinnel és metforminnal
ECSP982534A (es) Nuevo metodo de tratamiento